Fatima Samia, Ahmed Rashida, Ahmed Arsalan
Section of Histopathology, Department of Pathology and Microbiology, The Aga Khan University Hospital, Karachi, Pakistan.
Asian Pac J Cancer Prev. 2011;12(6):1385-8.
The epidemiology of Hodgkin lymphoma (HL) shows a wide geographic variation with regard to age, gender, histological subtypes and their association with Epstein-Barr virus. The proportion of EBV positive cases appears higher in developing than in developed countries. EBV is a common infection in Pakistan due to poor socioeconomic conditions, but reports regarding HL subtypes have been rather selective. Our aims were to establish the relative frequencies of the five subtypes of Hodgkin lymphoma, to determine their associations with Epstein-Barr virus, and finally to establish whether such association follows patterns seen in developing or developed countries. Among 100 cases, the male: female ratio was 4.5:1, with an age range of 4-82 years and an average of 26.6 years. Similar to the subtype distribution in developing countries, mixed cellularity was the commonest 57%, followed by nodular sclerosis 35%, lymphocyte rich 6% and nodular lymphocyte predominant 2%. EBV-LMP1 staining was demonstrated in 41/57 (71%) of the mixed cellularity and the 19/35 (54.2%) of nodular sclerosis subtypes. All 6 cases of lymphocyte rich and 2 cases of nodular lymphocyte predominant were negative for EBV-LMP 1. Speculation about prognostic effects of EBV infection on the course of HL are tempting. Thus the EBV-positive HL could in the future prove to be an excellent candidate for targeted cellular immunotherapy.
霍奇金淋巴瘤(HL)的流行病学在年龄、性别、组织学亚型及其与爱泼斯坦-巴尔病毒的关联方面存在广泛的地域差异。EBV阳性病例的比例在发展中国家似乎高于发达国家。由于社会经济条件差,EBV在巴基斯坦是一种常见感染,但关于HL亚型的报告相当有选择性。我们的目的是确定霍奇金淋巴瘤五种亚型的相对频率,确定它们与爱泼斯坦-巴尔病毒的关联,最后确定这种关联是否遵循发展中国家或发达国家所见的模式。在100例病例中,男女比例为4.5:1,年龄范围为4至82岁,平均年龄为26.6岁。与发展中国家的亚型分布相似,混合细胞型最为常见,占57%,其次是结节硬化型,占35%,淋巴细胞丰富型占6%,结节性淋巴细胞为主型占2%。在混合细胞型的41/57(71%)和结节硬化型的19/35(54.2%)中检测到EBV-LMP1染色。所有6例淋巴细胞丰富型和2例结节性淋巴细胞为主型的EBV-LMP1均为阴性。推测EBV感染对HL病程的预后影响很诱人。因此,EBV阳性的HL未来可能被证明是靶向细胞免疫治疗的极佳候选者。